Results 31 to 40 of about 820,674 (377)
New England Journal of Medicine, 2000 BACKGROUND AND METHODS We examined the influence of viral load in relation to other risk factors for the heterosexual transmission of human immunodeficiency virus type 1 (HIV-1). In a community-based study of 15,127 persons in a rural district of Uganda,
T. Quinn +8 more
semanticscholar +1 more source
Human immunodeficiency virus and leishmaniasis
Journal of Global Infectious Diseases, 2010 The Leishmaniases are a group of diseases transmitted to humans by the bite of a sandfly, caused by protozoan parasites of the genus Leishmania. Various Leishmania species infect humans, producing a spectrum of clinical manifestations. It is estimated that 350 million people are at risk, with a global yearly incidence of 1-1.5 million for cutaneous and
Maria Teresa Ochoa +2 more
openaire +4 more sources
Clinical Infectious Diseases, 2018 Testing for human immunodeficiency virus resistance in drug-naive individuals and in patients in whom antiretroviral treatment (ART) is failing, and the appreciation of the role of testing, are crucial to the prevention and management of failure of ART.
H. Günthard +7 more
semanticscholar +1 more source
human immunodeficiency virus [PDF]
, 2009 Gastrointestinal disease is an important cause of morbidity and mortality in patients infected with the human immunodeficiency virus (HIV) and those with the acquired immunodeficiency syndrome (AIDS). Although one or more opportunistic infections are often found in these patients, there is a subgroup in which no pathogens are found despite extensive ...
Gupta, R, Angus, B
openaire +4 more sources
Multiobjective optimization to a TB-HIV/AIDS coinfection optimal control problem [PDF]
Comput. Appl. Math. 37 (2018), no. 2, 2112--2128, 2017 We consider a recent coinfection model for Tuberculosis (TB), Human Immunodeficiency Virus (HIV) infection and Acquired Immunodeficiency Syndrome (AIDS) proposed in [Discrete Contin. Dyn. Syst. 35 (2015), no. 9, 4639--4663]. We introduce and analyze a multiobjective formulation of an optimal control problem, where the two conflicting objectives are ...
arxiv +1 more source
Clinical Infectious Diseases, 2018 Glecaprevir/pibrentasvir is approved to treat hepatitis C virus genotype 1–6 infection. Patients coinfected with human immunodeficiency virus type 1 achieved high cure rates after 8- (without cirrhosis) and 12- (compensated cirrhosis) week treatment ...
J. Rockstroh +21 more
semanticscholar +1 more source
Journal of Medical Case Reports, 2012 Introduction Most individuals infected with human immunodeficiency virus-1, in the absence of antiretroviral therapy, exhibit persistent virus replication and declining CD4+ cell numbers, and progress to acquired immunodeficiency syndrome within 10 years
Killian Michael +4 more
doaj +1 more source
Mixed models for longitudinal left-censored repeated measures [PDF]
Comput Methods Programs Biomed 74, 3 (06/2004) 255-60, 2007 Longitudinal studies could be complicated by left-censored repeated measures. For example, in Human Immunodeficiency Virus infection, there is a detection limit of the assay used to quantify the plasma viral load. Simple imputation of the limit of the detection or of half of this limit for left-censored measures biases estimations and their standard ...
arxiv +1 more source
New England Journal of Medicine, 1997 BACKGROUND The efficacy and safety of adding a protease inhibitor to two nucleoside analogues to treat human immunodeficiency virus type 1 (HIV-1) infection are not clear.
S. Hammer +17 more
semanticscholar +1 more source
Journal of Microbiology, Immunology and Infection, 2017 Background: The fourth-generation human immunodeficiency virus (HIV) combination assay, which can simultaneously detect the presence of anti-HIV antibody and HIV antigen, has been shown to shorten the window period in HIV diagnosis compared with the ...
Chun-Kai Chang +12 more
doaj +1 more source